Athenex Inc 's

• ATNX's Stock Performance relative to its Competitors

Aprea Therapeutics Inc Share Performance +42.01% 30 Days

Aprea Therapeutics Inc Profile Aprea Therapeutics Inc is a biopharmaceutical company with a business model focused on developing and commercializing innovative cancer therapies. They aim to leverage their proprietary discovery platform to identify and develop small molecules that selectively target and restore the tumor suppressor protein p53. Their business strategy includes conducting clinical trials, seeking regulatory approvals, and partnering with other organizations for commercialization and distribution. More about Aprea Therapeutics Inc 's Market Share

Regenerx Biopharmaceuticals inc Share Performance +40.00% This Quarter

Regenerx Biopharmaceuticals inc Profile Regenerx Biopharmaceuticals Inc operates with a business model based on developing and commercializing innovative therapeutic products. They focus on utilizing regenerative medicine to address unmet medical needs in various therapeutic areas, including ophthalmology and dermatology. The company aims to identify promising drug candidates, conduct clinical trials, and ultimately bring their products to market to improve patients' lives. More about Regenerx Biopharmaceuticals inc 's Market Share

Rein Therapeutics Inc Share Performance -45.03% One Year

Rein Therapeutics Inc Profile More about Rein Therapeutics Inc 's Market Share

Rayzebio Inc Share Performance +175.04% This Quarter

Rayzebio Inc Profile Rayzebio Inc is a biotechnology company that operates on a business model focused on developing innovative cancer therapies by leveraging cutting-edge technologies and advanced research methods. They aim to identify and target key biological pathways to provide personalized treatment options for patients, ultimately improving cancer outcomes. More about Rayzebio Inc 's Market Share

Sonnet Biotherapeutics Holdings Inc Share Performance -69.35% Over The Past 5 Days

Sonnet Biotherapeutics Holdings Inc Profile Sonnet Biotherapeutics Holdings Inc's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of cancer and other diseases. More about Sonnet Biotherapeutics Holdings Inc 's Market Share

Sources: Athenex Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 8:06 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Athenex Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.